Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19

INTRODUCTION: To reduce Coronavirus Disease 2019 (COVID-19)-related mortality and morbidity, widely available oral COVID-19 treatments are urgently needed. Certain antidepressants, such as fluvoxamine or fluoxetine, may be beneficial against COVID-19. OBJECTIVES: The main objective was two-fold: (i)...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoertel, N., Sanchez-Rico, M., Kornhuber, J., Gulbins, E., Reiersen, A., Lenze, E., Fritz, B. A., Jalali, F., Mills, E., Cougoule, C., Carpinteiro, A., Mühle, C., Becker-Flegler, K. A., Boulware, D. R., Blanco, C., Alvarado, J. M., Strub-Wourgaft, N., Lemogne, C., Limosin, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596647/
http://dx.doi.org/10.1192/j.eurpsy.2023.317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596647/
http://dx.doi.org/10.1192/j.eurpsy.2023.317

Ejemplares similares